REC-1245 An investigational RBM39 degrader in Phase 1 development for selected solid tumors and lymphoma.
Visit productCosigns Received
Be the first Cosign
Put your name behind REC-1245.
Add it to your Products I use list and share why you use it.
REC-1245 An investigational RBM39 degrader in Phase 1 development for selected solid tumors and lymphoma.
Visit productBe the first Cosign
Add it to your Products I use list and share why you use it.